Two Decades of Innovation: Balachandar Jeganathan Talks Tech & Impact

I am Balachandar Jeganathan, an innovative and results-driven software developer with over 20 years of experience specializing in the medical device and semiconductor industries. I hold dual master's degrees in Computer Science and Artificial Intelligence/Machine Learning, and have a proven track record of leveraging advanced technologies to drive impactful innovations.

My expertise spans AI/ML solutions, diagnostic systems, and semiconductor applications, with published research in areas such as Generative Adversarial Networks (GANs) and diabetic retinopathy detection. I am also an IEEE Senior Member and have contributed as a judge and reviewer for STEM fairs and scientific journals.

Currently, I serve as Senior Software Engineer at ASML in San Jose, CA, where I contribute to the design, development, and testing of software solutions for advanced semiconductor manufacturing and inspection systems. My responsibilities include implementing machine learning models for defect classification and collaborating with cross-functional teams to deliver scalable, efficient software.

ASML is a global leader in semiconductor manufacturing technology, known for its cutting-edge eBeam wafer inspection systems. These systems are foundational for ensuring defect-free semiconductor production, which is critical for the reliability of chips used in everything from consumer electronics to AI and defense systems.

ASML operates in the semiconductor industry, which is characterized by rapid technological advancements, high precision, and the need for continuous innovation. The industry is essential for enabling progress in AI, IoT, consumer electronics, and national security. Key characteristics include:

• Focus on nanoscale precision and defect detection.

• Integration of AI and machine learning for automation and quality control.

• High demand for reliability, scalability, and efficiency in manufacturing processes.

Winning the Platinum Award in Information Technology - AI Automation at the 2025 TITAN Business Awards is a profound honor. It recognizes my individual dedication and innovation in the field. This distinction validates my approach to leveraging AI for transformative healthcare diagnostics and inspires me to continue pursuing even greater advancements.

Receiving an international award like the TITAN Business Awards has significantly elevated our organization's profile. It has enhanced our credibility, attracted global attention to our AI-driven diagnostic solutions, and opened new opportunities for collaboration and adoption in clinical and industrial settings.

Developing the Automated Plasma Cell Segmentation system involved several challenges:

• Curating and annotating a novel dataset for plasma cell segmentation.

• Optimizing deep learning models for high accuracy in a complex medical context.

• Ensuring compliance with data privacy and regulatory standards.

• Overcoming resistance to AI adoption in clinical workflows.

• Marketing the solution required clear communication of its value and building trust with healthcare professionals.

My ideation process is rooted in identifying real-world problems, conducting thorough research, and iteratively developing solutions using the latest technologies. I prioritize user-centric design, continuous feedback, and cross-disciplinary collaboration to ensure that innovations are both impactful and practical.

A successful organization is one that fosters innovation, collaboration, and continuous learning. It empowers its members, values diversity of thought, and maintains a clear focus on delivering solutions that address critical needs while upholding ethical standards and social responsibility.

Our success stems from a commitment to excellence, staying at the forefront of technology, and building strong partnerships across the industry. By aligning our work with global priorities-such as improving healthcare outcomes and strengthening domestic semiconductor capabilities-we have positioned ourselves as leaders in innovation.

Being based in the United States has provided access to a robust innovation ecosystem, world-class research institutions, and initiatives like the CHIPS Act, which support domestic semiconductor manufacturing and technological leadership.

The pandemic posed challenges such as supply chain disruptions and limited in-person collaboration. We overcame these by adopting agile development practices, leveraging remote collaboration tools, and focusing on digital transformation to maintain productivity and innovation.

I am most excited about:

• The integration of AI and machine learning into healthcare and manufacturing.

• The rise of smart, connected devices (IoT).

• Advances in personalized medicine and precision diagnostics.

I recommend:

• Professional organizations like IEEE for networking and knowledge sharing.

• Online platforms such as Udemy, Pluralsight for technical learning.

• Industry conferences and journals for staying updated on trends.

• Mentorship programs and STEM initiatives to foster continuous growth.

The business industry will become increasingly data-driven, with AI and automation transforming operations, decision-making, and product development. There will be greater emphasis on sustainability, ethical AI, and global collaboration to address complex challenges.

I am inspired by renowned leaders who exemplify both technical excellence and a commitment to societal impact across their respective industries. In artificial intelligence, Dr. Fei-Fei Li stands out for her pioneering work in computer vision and her advocacy for ethical AI. In medical technology, Dr. Varian (Varian Medical Systems, founded by Donald G. Varian) is recognized for revolutionizing cancer treatment through innovations in radiation therapy.

The key to success is a relentless pursuit of learning, adaptability, and a passion for solving meaningful problems. My advice: Embrace challenges as opportunities, value teamwork, and never lose sight of the broader impact your work can have on society.